Reference dose for perchlorate based on thyroid hormone change in pregnant women as the critical effect

Regulatory Toxicology and Pharmacology

Volumn 39, Issue 1, 2004, Pages 44-65

  Strawson, Joan ^a   Zhao, Qiyu ^a   Dourson, Michael ^a  

^a Toxicology Excellence for Risk Assessment   (United States)

Author keywords

Human; Perchlorate; Reference dose; RfD; TSH

Indexed keywords

PERCHLORATE; THYROID HORMONE;

ANALYTIC METHOD; ARTICLE; DOSE RESPONSE; IODINATION; PERINATAL DRUG EXPOSURE; PREGNANT WOMAN; PRIORITY JOURNAL; REFERENCE VALUE; STATISTICAL ANALYSIS; THYROXINE BLOOD LEVEL; TOXICOKINETICS;

ANIMALIA; RODENTIA;

EID: 1642554770     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yrtph.2003.10.003     Document Type: Article

References (68)

1. Argus Research Laboratories, Inc., 1998. A neurobehavioral study of ammonium perchlorate administered orally in drinking water to rats [report amendment: July 27]. Argus Research Laboratories, Inc., Horsham, PA, Protocol No. 1613-002.
2. Argus Research Laboratories, Inc., 2001. Hormone, thyroid and neurohistological effects of oral (drinking water) exposure to ammonium perchlorate in pregnant and lactating rats and in fetuses and nursing pups exposed to ammonium perchlorate during gestation or via maternal milk. Argus Research Laboratories, Inc., Horsham, PA, Protocol No. 1416-003.
3. Barnes D.G., Dourson M.L. Reference dose (RfD): description and use in health risk assessments. Regul. Toxicol. Pharm. 8:1988;471-486.
4. Bartalena L., Brogioni S., Grasso L., Bogazzi F., Burelli A., Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J. Clin. Endocrinol. 81:1966;2930-2933.
5. Barzilai D., Sheinfeld M. Fatal complications following use of potassium perchlorate in thyrotoxicosis: report of two cases and a review of the literature. Israel J. Med. Sci. 2:1966;453-456.
6. Bekkedal, M.Y.V., Carpenter, T., Smith, J., Ademujohn, C., Maken, D., Mattie, D.R., 2000. A neurodevelopmental study of the effects of oral ammonium perchlorate exposure on the motor activity of pre-weanling rat pups. Naval Health Research Center Detachment, Neurobehavioral Effects Laboratory, Wright-Patterson Air Force Base, OH. Report No. TOXDET-00-03.
7. Boyages S.C., Collins J.K., Maberly G.F., Jupp J.J., Morris J., Eastman C.J. Iodine deficiency impairs intellectual and neuromotor development in apparently-normal persons. A study of rural inhabitants of north-central China. Med. J. Austr. 150:1989;676-682.
8. Brechner R.J., Parkhurst G.D., Humble W.O., Brown M.B., Herman W.H. Ammonium perchlorate contamination of Colorado River drinking water is associated with abnormal thyroid function in newborns in Arizona. J. Occ. Environ. Med. 42:2000;777-782.
9. Burleson Research Technologies, Inc. (BRT), 2000. Ammonium perchlorate: effect on immune function. Quality assurance audit: Study No. BRT 19990524 - plaque forming cell (PFC) assay; Study No. BRT 19990525 - local lymph node assay (LLNA) in mice, Raleigh, NC.
10. Caldwell, D.J., King Jr., J.H., Kinkead, E.R., Wolfe, R.E., Narayanan, L., Mattie, D.R., 1996. Results of a fourteen day oral-dosing toxicity study of ammonium perchlorate. In: Proceedings of the 1995 JANNAF Safety and Environmental Protection Subcommittee Meeting: vol. 1, December; Tampa, FL. Columbia, MD: Chemical Propulsion Information Agency, Joint Army, Navy, NASA, Air Force (JANNAF) interagency propulsion committee publication, p. 634.
11. ′ -triiodothyronine in the protection of the fetal brain J. Clin. Invest. 86:1990;889-899.
12. Cao X.Y., Jiang X.M., Dou Z.H., Rakeman M.A., Zhang M.L., O'Donnell K., Ma T., Annette K., DeLong N., DeLong G.R. Timing of vulnerability of the brain to iodine deficiency in endemic crentinism. New Engl. J. Med. 331:1994;1739-1744.
13. Capen C.C. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol. Path. 25:1997;39-48.
14. Capen C.C. Toxic Responses of the Endocrine System. Chapter 21 of Casarett and Doull's Toxicology: The Basic Science of Poisons. sixth ed. 2001;McGraw-Hill, New York, NY. p. 724.
15. Carrasco N. Iodide transport in the thyroid gland. Biochim. Biophys. Acta. 1154:1993;65-82.
16. Connell J.M. Long-term use of potassium perchlorate. Postgrad. Med. J. 57:1981;516-517.
17. Crump C., Michaud P., Tellez R., Reyes C., Gonzalez G., Montgomery E.L., Crump K.S., Lobo G., Becerra C., Gibbs J.P. Does perchlorate in drinking water affect thyroid function in newborns or school-age children? J. Occ. Environ. Med. 42:2000;603-612.
18. Dourson M.L. Methods for establishing oral reference doses (RfDs). Mertz W., Abernathy C.O., Olin S.S. Risk Assessment of Essential Elements. 1994;51-61 ILSI Press, Washington, DC.
19. Dunn, J., 2003. The extent and causes of iodine deficiency in the USA. Perchlorate State of the Art Symposium. University of Nebraska Medical Center, Omaha, Nebraska, September 23.
20. Gibbs J.P., Ahmad R., Crump K.S., Houck D.P., Leveille T.S., Findley J.E., Francis M. Evaluation of a population with occupational exposure to airborne ammonium perchlorate for possible acute or chronic effects on thyroid function. J. Occ. Environ. Med. 40:1998;1072-1082.
21. Gibbs, J., 2003. A Natural Laboratory: Northern Chile. Perchlorate State of the Art Symposium. University of Nebraska Medical Center, Omaha, Nebraska, September 30.
22. Greenspan F.S. The role of fine-needle aspiration biopsy in the management of palpable thyroid nodules. Am. J. Clin. Pathol. 108(4 Suppl. 1):1997;S26-S30.
23. Greer, M.A., Goodman, G., Pleus, R.C., Greer, S.E., 2000. Does environmental perchlorate exposure alter human thyroid function? Determination of the dose-response for inhibition of radioiodine uptake. In: Abstracts of the 12th International Thyroid Congress, October, Kyoto, Japan. Endocr. J. 47 (suppl.), 146.
24. Greer M., Goodman G., Pleus R., Greer S. Health effects assessment for environmental perchlorate contamination: The dose response assessment for inhibition of thyroidal radioiodine uptake in humans. Environ. Health Perspect. 110:2002;927-937.
25. Haber L.T., Dollarhide J.S., Maier A., Dourson M.L. Noncancer Risk Assessment: Principles and Practice in Environmental and Occupational Settings. Bingham E., Cohrssen B., Powell C.H. Patty's Toxicology. fifth ed. 2001;169-232 Wiley and Sons, New York, NY.
26. Haddow J.E., Palomaki G.E., Allan W.C., Williams J.R., Knight G.J., Gagnon J., O'Heir C.E., Mitchell M.L., Hermos R.J., Waisbren S.E., Faix J.D., Klein R.Z. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New Engl. J. Med. 341:1999;549-555.
27. Hill R.N., Erdreich L.S., Paynter O.E., Roberts P.A., Rosenthal S.L., Wilkinson C.F. Thyroid follicular cell carcinogenesis. Fundam. Appl. Toxicol. 12:1989;629-697.
28. Hollowell J.G. Jr., Hannon W.H. Teratogen update: iodine deficiency, a community teratogen. Teratology. 55:1997;389-405.
29. Hollowell J.G., Staehling N.W., Hannon W.H., Flanders D.W., Gunter E.W., Maberly G.F., Braverman L.E., Pino S., Miller D.T., Garbe P.L., DeLozier D.M., Jackson R.J. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J. Clin. Endocrinol. Metab. 83:1998;3401-3408.
30. International Programme on Chemical Safety (IPCS), 1994. Environmental Health Criteria No. 170: Assessing human health risks of chemicals: Derivation of guidance values for health-based exposure limits. World Health Organization, Geneva.
31. Keil, D., Warren, D.A., Jenny, M., EuDaly, J., Dillard, R., 1999. Effects of ammonium perchlorate on immunotoxicological, hematological, and thyroid parameters in B6C3F1 female mice. Final Report, Medical University of South Carolina, Department of Medical Laboratory Sciences, Charleston, SC. Report No. DSWA01-97-0008.
32. Kessler F.J., Krüskemper H.J. Experimentelle Schilddrü sentumoren durch mehrjährige Zufuhr von Kaliumperchlorat [Experimental thyroid tumors caused by long-term potassium perchlorate administration]. Klin. Wochenschr. 44:1966;1154-1156.
33. Lamm S.H., Braverman L.E., Li F.X., Richman K., Pino S., Howearth G. Thyroid health status of ammonium perchlorate workers: a cross-sectional occupational health study. J. Occ. Environ. Med. 41:1999;248-260.
34. Lawrence J.E., Lamm S.H., Pino S., Richman K., Braverman L.E. The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid. 10:2000;659-663.
35. Lawrence J., Lamm S., Braverman L.E. Low dose perchlorate (3. mg daily) and thyroid function [letter] Thyroid. 11:2001;295.
36. Li Z., Li F.X., Byrd D., Deyhle G.M., Sesser D.E., Skeels M.R., Lamm S.H. Neonatal thyroxine level and perchlorate in drinking water. J. Occ. Environ. Med. 42:2000;200-205.
37. Li F.X., Byrd D.M., Deyhle G.M., Sesser D.E., Skeels M.R., Katkowsky S.R., Lamm S.H. Neonatal thyroid-stimulating hormone level and perchlorate in drinking water. Teratology. 62:2000;429-431.
38. Li F.X., Squartsoff L., Lamm S.H. Prevalence of thyroid diseases in Nevada counties with respect to perchlorate in drinking water. J. Occ. Environ. Med. 43:2001;630-634.
39. Loh K.C. Amiodarone-induced thyroid disorders: a clinical review. Postgrad. Med. J. 76:2000;133-140.
40. Mattie, et al., 2003. A Natural Laboratory: Northern Chile. Perchlorate State of the Art Symposium. University of Nebraska Medical Center, Omaha, Nebraska, September 30.
41. Meek M., Renwick A., Ohanian E., Dourson M., Lake B., Naumann B., Vu V. Guidelines for application of compound specific adjustment factors (CSAF) in dose/concentration response assessment. Comments. Toxicol. 7:2001;575-590.
42. Merrill, E., 2001. Consultative letter, AFRL-HE-WP-CL-2001-0004, QA/QC audit. Report for the study of perchlorate pharmacokinetics and inhibition of radioactive iodine uptake (RAIU) by the thyroid in humans (CRC protocol #628) [memorandum with attachments to Annie M. Jarabek]. Wright-Patterson AFB, Dayton, OH, Air Force Research Laboratory, May 10.
43. Merrill, E.A., Clewell, R.A., Robinson, P.J., Jarabek, A.M., Gearhart, J.M., Sterner, T.R., Fisher, J.W., 2003. PBPK model for iodide and perchlorate kinetics and perchlorate-induced inhibition of radioiodide uptake in humans (in press).
44. Morgans M.E., Trotter W.R. Potassium perchlorate in thyrotoxicosis [letter]. Brit. Med. J. (October 8):1960;1086-1087.
45. Morreale de Escobar G., Obregón M.J., Escobar del Ray F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J. Clin. Endocrinol. Metab. 85:2000;3975-3987.
46. Narayanan, L., 2000. Consultative letter, AFRL-HE-WP-CL-2000-0034. Thyroid hormone and TSH co-laboratory study report [memorandum with attachments to Annie Jarabek]. Wright-Patterson Air Force Base, Dayton, OH, Air Force Research Laboratory, June 15.
47. Scanlon, 1996. As cited in Greer et al. (2000).
48. San, R.C., Clarke, J.J., 1999. In vitro mammalian cell gene mutation test (L5178Y/TK+/- mouse lymphoma assay). Rockville, MD, BioReliance Study No. G98BA06.702. Available from < http://www.tera.org/perchlorate/ 2nd%20study%20final.pdf
49. Sharma, S., Gao, P., 1998. Genotoxicity assays for ammonium perchlorate. Final Report. Mantech Environmental Technology Study No. 6100-001. Available from < http://www.tera.org/perchlorate/mantech%20genotoxicity.pdf
50. Siglin J.C., Mattie D.R., Dodd D.E., Hildebrandt P.K., Baker W.H. A 90-day drinking water toxicity study in rats of the environmental contaminant ammonium perchlorate. Toxicol. Sci. 57:1998;61-74.
51. Stanbury J.B., Wyngaarden J.B. Effect of perchlorate on the human thyroid gland. Metab. Clin. Exp. 1:1952;533-539.
52. Susarla S., Collette T.W., Garrison A.W., Wolfe N.L., McCutcheon S.C. Perchlorate identification in fertilizers. Environ. Sci. Tech. 33:1999;3469-3472.
53. Tellez, R.T., Chacon, P.M., Gibbs, J., Crump, C., Abarca, C.R., 2003. Chronic environmental exposure to perchlorate and thyroid function during pregnancy and the neonatal period. Protocol and preliminary results available from < http://www.tera.org/perchlorate/welcome. htm#human.
54. Ting, D., Howard, R., Fan, A., 2001. Human health risk assessment on perchlorate exposure through drinking water. California Environmental Protection Agency (Cal EPA), Oakland, California. Presentation at the Society of Risk Analysis, December.
55. Toxicology Excellence for Risk Assessment (TERA), 2002. Use of human data in risk assessment. Comments submitted to U.S. EPA, February 19.
56. University of Nebraska, 2003. Perchlorate State of the Science Symposium. University of Nebraska Medical Center, Omaha, Nebraska. September 29th to October 1. Available from < http://www.unmc.edu/coned
57. U.S. Environmental Protection Agency, 1998. Guidelines for Neurotoxicity Risk Assessment. Federal Register, May 14, vol. 63, pp. 26926-26954.
58. U.S. Environmental Protection Agency, 1999. Exposure Factors Handbook. Office of Research and Development. Washington, DC, February. EPA/600/C-99/001.
59. U.S. Environmental Protection Agency, 2002. A Review of the Reference Dose and Reference Concentration Processes. Risk Assessment Forum. Washington, DC, May. EPA/630/P-02/002A.
60. U.S. Environmental Protection Agency, 2003a. Integrated Risk Information System (IRIS). Glossary of Terms. Office of Research and Development. Washington, DC. Available online: http://www.USEPA.gov/iris.
61. U.S. Environmental Protection Agency, 2003b. Disposition of Comments and Recommendations for Revisions to "Perchlorate Environmental Contamination: Toxicological Review and Risk Characterization External Review Draft (January 16, 2002)." National Center for Environmental Assessment, Washington, DC. October 27.
62. Wenzel K.W., Lente J.R. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action on thionamide drugs. J. Clin. Endocrinol. Metab. 58:1984;62-69.
63. Wolff J. Perchlorate and the thyroid gland. Pharmacol. Rev. 50:1998;89-105.
64. Wyngaarden J.B., Wright B.M., Ways P. The effect of certain anions upon the accumulation and retention of iodide by the thyroid gland. Endocrinology. 50:1952;537-549.
65. York R.G., Brown W.R., Girard M.F., Dollarhide J.S. Oral (drinking water) developmental toxicity study of ammonium perchlorate in New Zealand white rabbits. Int. J. Toxicol. 20:2001;199-207.
66. York R.G., Brown W.R., Girard M.F., Dollarhide J.S. Two-generation study of ammonium perchlorate in drinking water in rats evaluates thyroid toxicity. Int. J. Toxicol. 20:2001;183-197.
67. Yu, K.O., 2000. Consultative letter, AFRL-HE-WP-CL-2000-0038. Tissue distribution and inhibition of iodide uptake in the thyroid by perchlorate with corresponding hormonal changes in pregnant and lactating rats (drinking water study) [memorandum with attachment to Annie Jarabek]. Wright-Patterson Air Force Base, Dayton, OH, Air Force Research Laboratory, June 28.
68. Yu K.O., Narayanan L., Mattie D.R., Godfrey R.J., Todd P.N., Sterner T.R., Mahle D.A., Lumpkin M.H., Fisher J.W. The pharmacokinetics of perchlorate and its effect on the hypothalamus-pituitary-thyroid axis in the male rat. Toxicol. Appl. Pharmacol. 182:2002;148-159.